相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Residual Amount of HBV DNA in Serum is Related to Relapse in Chronic Hepatitis B Patients After Cessation of Nucleos(t)ide Analogs
Jian-ning Jiang et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2015)
STOPPING TENOFOVIR DISOPROXIL FUMARATE (TDF) TREATMENT AFTER LONG TERM VIROLOGIC SUPPRESSION IN HBeAg-NEGATIVE CHB: WEEK 48 INTERIM RESULTS FROM AN ONGOING RANDOMIZED, CONTROLLED TRIAL (FINITE CHB)
T. Berg et al.
JOURNAL OF HEPATOLOGY (2015)
Discontinuation of long-term NA therapy in HBeAg-negative chronic hepatitis B
Stephanos Hadziyannis et al.
GUT (2015)
Treatment cessation of entecavir in Asian patients with hepatitis B e antigen negative chronic hepatitis B: a multicentre prospective study
Wai-Kay Seto et al.
GUT (2015)
Optimal therapy for chronic hepatitis B: hepatitis B virus combination therapy?
Jorg Petersen et al.
LIVER INTERNATIONAL (2015)
Treatment cessation in noncirrhotic, e-antigen negative chronic hepatitis B is safe and effective following prolonged anti-viral suppression with nucleosides/nucleotides
V. R. Patwardhan et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Off-treatment virologic relapse and outcomes of re-treatment in chronic hepatitis B patients who achieved complete viral suppression with oral nucleos(t)ide analogs
Hyung Rae Sohn et al.
BMC INFECTIOUS DISEASES (2014)
Long-term outcomes after nucleos(t)ide analogue discontinuation in HBeAg-positive chronic hepatitis B patients
D. He et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
The role of hepatitis B surface antigen quantification in predicting HBsAg loss and HBV relapse after discontinuation of lamivudine treatment
Chien-Hung Chen et al.
JOURNAL OF HEPATOLOGY (2014)
Relapse rates in chronic hepatitis B naive patients after discontinuation of antiviral therapy with entecavir
E. Ridruejo et al.
JOURNAL OF VIRAL HEPATITIS (2014)
Long-term outcomes after nucleos(t)ide analogues discontinuation in chronic hepatitis B patients with HBeAg-negative
Dengming He et al.
BMC INFECTIOUS DISEASES (2013)
Off-Therapy Durability of Response to Entecavir Therapy in Hepatitis B e Antigen-Negative Chronic Hepatitis B Patients
Wen-Juei Jeng et al.
HEPATOLOGY (2013)
Relapse of Chronic Hepatitis B After Discontinuation of Nucleos(t)ide Analogs: Is the Glass Half Full or Half Empty?
Jurrien G. P. Reijnders et al.
HEPATOLOGY (2013)
Should lamivudine monotherapy be stopped or continued in patients infected with hepatitis B with favorable responses after more than 5 years of treatment?
Jung Hyun Kwon et al.
JOURNAL OF MEDICAL VIROLOGY (2013)
Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study
Patrick Marcellin et al.
LANCET (2013)
Why do I treat HBeAg-negative chronic hepatitis B patients with nucleos(t)ide analogues?
George V. Papatheodoridis
LIVER INTERNATIONAL (2013)
Durability after discontinuation of nucleos(t) ide therapy in chronic HBeAg negative hepatitis patients
Young Jip Kim et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2013)
A prospective clinical study in hepatitis B e antigen-negative chronic hepatitis B patients with stringent cessation criteria for adefovir
Minghao Ha et al.
ARCHIVES OF VIROLOGY (2012)
Sustained Responses and Loss of HBsAg in HBeAg-Negative Patients With Chronic Hepatitis B Who Stop Long-Term Treatment With Adefovir
Stephanos J. Hadziyannis et al.
GASTROENTEROLOGY (2012)
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update
Yun-Fan Liaw et al.
HEPATOLOGY INTERNATIONAL (2012)
High Frequency of Recurrent Viremia After Hepatitis B e Antigen Seroconversion and Consolidation Therapy
Kevin T. Chaung et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2012)
EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
George Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2012)
Two-stage meta-analysis of survival data from individual participants using percentile ratios
Jessica K. Barrett et al.
STATISTICS IN MEDICINE (2012)
Durability of viral response after off-treatment in HBeAg positive chronic hepatitis B
Myeong Jun Song et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Prediction of off-treatment response to lamivudine by serum hepatitis B surface antigen quantification in hepatitis B e antigen-negative patients
Henry L-Y Chan et al.
ANTIVIRAL THERAPY (2011)
Poor durability of lamivudine effectiveness despite stringent cessation criteria: A prospective clinical study in hepatitis B e antigen-negative chronic hepatitis B patients
Feng Liu et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
Entecavir Treatment for up to 5 Years in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B
Ting-Tsung Chang et al.
HEPATOLOGY (2010)
On-treatment serum HBsAg level is predictive of sustained off-treatment virologic response to telbivudine in HBeAg-positive chronic hepatitis B patients
Wei Cai et al.
JOURNAL OF CLINICAL VIROLOGY (2010)
Stringent cessation criterion results in better durability of lamivudine treatment: a prospective clinical study in hepatitis B e antigen-positive chronic hepatitis B patients
L. Wang et al.
JOURNAL OF VIRAL HEPATITIS (2010)
Extended lamivudine consolidation therapy in hepatitis B e antigen-positive chronic hepatitis B patients improves sustained hepatitis B e antigen seroconversion
Yuan-Hung Kuo et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2010)
The Duration of Lamivudine Therapy for Chronic Hepatitis B: Cessation vs. Continuation of Treatment After HBeAg Seroconversion
James Fung et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Chronic Hepatitis B: Update 2009
Anna S. F. Lok et al.
HEPATOLOGY (2009)
Withdrawal of lamivudine in HBeAg-positive chronic hepatitis B patients after achieving effective maintained virological suppression
Chau-Ting Yeh et al.
JOURNAL OF CLINICAL VIROLOGY (2009)
Optimal duration of additional therapy after biochemical and virological responses to lamivudine in patients with HBeAg-negative chronic hepatitis B: a randomized trial
Masaru Enomoto et al.
HEPATOLOGY RESEARCH (2008)
Therapeutic strategies in the management of patients with chronic hepatitis B virus infection
George V. Popotheodoridis et al.
LANCET INFECTIOUS DISEASES (2008)
Sustained response after a 2-year course of lamivudine treatment of hepatitis B e antigen-negative chronic hepatitis B
SK Fung et al.
JOURNAL OF VIRAL HEPATITIS (2004)
Effects of adjusting for censoring on meta-analyses of time-to-event outcomes
CL Vale et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2002)
Meta-analysis of observational studies in epidemiology - A proposal for reporting
DF Stroup et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
分享论文
